These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 27092792)

  • 1. Blockade of glucagon signaling prevents or reverses diabetes onset only if residual β-cells persist.
    Damond N; Thorel F; Moyers JS; Charron MJ; Vuguin PM; Powers AC; Herrera PL
    Elife; 2016 Apr; 5():. PubMed ID: 27092792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal glucagon signaling and β-cell function after near-total α-cell ablation in adult mice.
    Thorel F; Damond N; Chera S; Wiederkehr A; Thorens B; Meda P; Wollheim CB; Herrera PL
    Diabetes; 2011 Nov; 60(11):2872-82. PubMed ID: 21926270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of the glucagon receptor gene before and after experimental diabetes reveals differential protection from hyperglycemia.
    Rivero-Gutierrez B; Haller A; Holland J; Yates E; Khrisna R; Habegger K; Dimarchi R; D'Alessio D; Perez-Tilve D
    Mol Metab; 2018 Nov; 17():28-38. PubMed ID: 30170980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute disruption of glucagon secretion or action does not improve glucose tolerance in an insulin-deficient mouse model of diabetes.
    Steenberg VR; Jensen SM; Pedersen J; Madsen AN; Windeløv JA; Holst B; Quistorff B; Poulsen SS; Holst JJ
    Diabetologia; 2016 Feb; 59(2):363-70. PubMed ID: 26537124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of glucagon and insulin action reveals a role for the GLP-1 receptor in endogenous glucose production.
    Jun LS; Millican RL; Hawkins ED; Konkol DL; Showalter AD; Christe ME; Michael MD; Sloop KW
    Diabetes; 2015 Mar; 64(3):819-27. PubMed ID: 25288673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor 21 (FGF21) and glucagon-like peptide 1 contribute to diabetes resistance in glucagon receptor-deficient mice.
    Omar BA; Andersen B; Hald J; Raun K; Nishimura E; Ahrén B
    Diabetes; 2014 Jan; 63(1):101-10. PubMed ID: 24062250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucagon receptor knockout mice are resistant to diet-induced obesity and streptozotocin-mediated beta cell loss and hyperglycaemia.
    Conarello SL; Jiang G; Mu J; Li Z; Woods J; Zycband E; Ronan J; Liu F; Roy RS; Zhu L; Charron MJ; Zhang BB
    Diabetologia; 2007 Jan; 50(1):142-50. PubMed ID: 17131145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. γ-aminobutyric acid modulates α-cell hyperplasia but not β-cell regeneration induced by glucagon receptor antagonism in type 1 diabetic mice.
    Gu L; Cui X; Lin X; Yang J; Wei R; Hong T; Yang K
    Acta Diabetol; 2023 Jan; 60(1):19-28. PubMed ID: 36129525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon receptor inhibition normalizes blood glucose in severe insulin-resistant mice.
    Okamoto H; Cavino K; Na E; Krumm E; Kim SY; Cheng X; Murphy AJ; Yancopoulos GD; Gromada J
    Proc Natl Acad Sci U S A; 2017 Mar; 114(10):2753-2758. PubMed ID: 28115707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon receptor knockout mice display increased insulin sensitivity and impaired beta-cell function.
    Sørensen H; Winzell MS; Brand CL; Fosgerau K; Gelling RW; Nishimura E; Ahren B
    Diabetes; 2006 Dec; 55(12):3463-9. PubMed ID: 17130493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperglycemia in rodent models of type 2 diabetes requires insulin-resistant alpha cells.
    Lee Y; Berglund ED; Yu X; Wang MY; Evans MR; Scherer PE; Holland WL; Charron MJ; Roth MG; Unger RH
    Proc Natl Acad Sci U S A; 2014 Sep; 111(36):13217-22. PubMed ID: 25157166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic alpha cell glucagon-liver FGF21 axis regulates beta cell regeneration in a mouse model of type 2 diabetes.
    Cui X; Feng J; Wei T; Zhang L; Lang S; Yang K; Yang J; Liu J; Sterr M; Lickert H; Wei R; Hong T
    Diabetologia; 2023 Mar; 66(3):535-550. PubMed ID: 36331598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon receptor knockout prevents insulin-deficient type 1 diabetes in mice.
    Lee Y; Wang MY; Du XQ; Charron MJ; Unger RH
    Diabetes; 2011 Feb; 60(2):391-7. PubMed ID: 21270251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoglycemic Effect of Combined Ghrelin and Glucagon Receptor Blockade.
    Mani BK; Uchida A; Lee Y; Osborne-Lawrence S; Charron MJ; Unger RH; Berglund ED; Zigman JM
    Diabetes; 2017 Jul; 66(7):1847-1857. PubMed ID: 28487437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of glucagon and glucagon-like peptide 1 receptors in mouse pancreatic alpha and beta cells in two models of alpha cell hyperplasia.
    Kedees MH; Grigoryan M; Guz Y; Teitelman G
    Mol Cell Endocrinol; 2009 Nov; 311(1-2):69-76. PubMed ID: 19647035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon receptor blockage inhibits β-cell dedifferentiation through FoxO1.
    Wang K; Cui X; Li F; Xia L; Wei T; Liu J; Fu W; Yang J; Hong T; Wei R
    Am J Physiol Endocrinol Metab; 2023 Jan; 324(1):E97-E113. PubMed ID: 36383639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon-receptor-antagonism-mediated β-cell regeneration as an effective anti-diabetic therapy.
    Xi Y; Song B; Ngan I; Solloway MJ; Humphrey M; Wang Y; Mondal K; Wu H; Liu W; Lindhout DA; Li D; Matern H; Kekatpure A; Haldankar R; Kaplan DD; Yang H; Pedersen O; Chen A; Zhou M; Winans B; Guo W; Kutach A; Fanget M; Fox M; Tang J; Zha J; Younis H; Shen D; DePaoli A; Tian H; Liu Z
    Cell Rep; 2022 May; 39(9):110872. PubMed ID: 35649369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid nanoparticle delivery of glucagon receptor siRNA improves glucose homeostasis in mouse models of diabetes.
    Neumann UH; Ho JSS; Chen S; Tam YYC; Cullis PR; Kieffer TJ
    Mol Metab; 2017 Oct; 6(10):1161-1172. PubMed ID: 29031717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic beta-cell overexpression of the glucagon receptor gene results in enhanced beta-cell function and mass.
    Gelling RW; Vuguin PM; Du XQ; Cui L; Rømer J; Pederson RA; Leiser M; Sørensen H; Holst JJ; Fledelius C; Johansen PB; Fleischer N; McIntosh CH; Nishimura E; Charron MJ
    Am J Physiol Endocrinol Metab; 2009 Sep; 297(3):E695-707. PubMed ID: 19602585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uncoupling protein 2 regulates reactive oxygen species formation in islets and influences susceptibility to diabetogenic action of streptozotocin.
    Lee SC; Robson-Doucette CA; Wheeler MB
    J Endocrinol; 2009 Oct; 203(1):33-43. PubMed ID: 19635759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.